Status:
RECRUITING
The Role of Probiotics in the Treatment of Endometriosis (ProMetrioS): a Randomised Double-blinded Placebo-controlled Cross-over Trial
Lead Sponsor:
The Gut Microbiome Center (Centar za crijevni mikrobiom)
Collaborating Sponsors:
Clinical Hospital Centre Zagreb
Conditions:
Endometriosis
Probiotics
Eligibility:
FEMALE
Up to 35 years
Phase:
NA
Brief Summary
ProMetrioS is a randomised blinded placebo-controlled cross-over trial investigating the effect of specific multistrain probiotics in patients with endometriosis. The aim of this clinical trial is to ...
Detailed Description
Patients will be recruited among the outpatient population of the National Center for Endometriosis, Department of Gynecological Surgery and Urology, Gynecology Department, University Hospital Center ...
Eligibility Criteria
Inclusion
- Minimum Age: - Maximum Age: 35 Years Sex: Female Gender Based: Ye - only women can participate in this study Accepts Healthy Volunteers: No
- adult subjects with stage III or IV endometriosis diagnosis confirmed by biopsy
Exclusion
- Age \> 35 years
- Immunocompromised patients
- Patients with chronic inflammatory diseases (e.g., autoimmune disorders)
- Pregnancy
- Use of supplements and foods with probiotics
- Use of immunosuppressant, antibiotic, proton pump inhibitors and corticosteroid drugs
- Use of probiotics product less than one month before start of study or during study
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06929364
Start Date
November 1 2024
End Date
November 30 2025
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Center Zagreb
Zagreb, Croatia, 10000